This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
26 Dec 2011

Sanofi to Relaunch Shan5 Vaccine in 2013

The vaccine was removed from the World Health Organization's prequalification list for 2012 after white sediment was discovered in some vials.

Sanofi subsidiary Shantha Biotech plans to relaunch the company's pentavalent Shan5 vaccine in 2013.

 

The vaccine was removed from the World Health Organization's prequalification list for 2012 after white sediment was discovered in some vials. No adverse effects were linked to the manufacturing snafu. Since then the Indian division has been working to implement corrective measures at its manufacturing facility, noted Sanofi CEO Chris Viehbacher.

 

The facility was originally slated for inspection in early 2012, but that Sanofi wanted to conduct more vaccine stability studies. "The company undertook extended studies on the vaccine, though Shan5 is absolutely ready for relaunch, only because the Sanofi management was very particular about its global reputation. Since

Related News